Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Apply
Maridebart Cafraglutide
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step